Regen Ther. 2021 Feb 24;16:81-89. doi: 10.1016/j.reth.2021.02.001. eCollection 2021 Mar.
Bile duct reconstruction using scaffold-free tubular constructs created by Bio-3D printer.
Regenerative therapy
Takashi Hamada, Anna Nakamura, Akihiko Soyama, Yusuke Sakai, Takayuki Miyoshi, Shun Yamaguchi, Masaaki Hidaka, Takanobu Hara, Tota Kugiyama, Mitsuhisa Takatsuki, Akihide Kamiya, Koichi Nakayama, Susumu Eguchi
Affiliations
Affiliations
- Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
- Department of Regenerative Medicine and Biomedical Engineering, Faculty of Medicine, Saga University, Japan.
- Department of Chemical Engineering, Faculty of Engineering, Graduate School, Kyushu University, Japan.
- Department of Molecular Life Sciences, Tokai University School of Medicine, Japan.
PMID: 33732817
PMCID: PMC7921183 DOI: 10.1016/j.reth.2021.02.001
Abstract
INTRODUCTION: Biliary strictures after bile duct injury or duct-to-duct biliary reconstruction are serious complications that markedly reduce patients' quality of life because their treatment involves periodic stent replacements. This study aimed to create a scaffold-free tubular construct as an interposition graft to treat biliary complications.
METHODS: Scaffold-free tubular constructs of allogeneic pig fibroblasts, that is, fibroblast tubes, were created using a Bio-3D Printer and implanted into pigs as interposition grafts for duct-to-duct biliary reconstruction.
RESULTS: Although the fibroblast tube was weaker than the native bile duct, it was sufficiently strong to enable suturing. The pigs' serum hepatobiliary enzyme levels remained stable during the experimental period. Micro-computed tomography showed no biliary strictures, no biliary leakages, and no intrahepatic bile duct dilations. The tubular structure was retained in all resected specimens, and the fibroblasts persisted at the graft sites. Immunohistochemical analyses revealed angiogenesis in the fibroblast tube and absence of extensions of the biliary epithelium into the fibroblast tube's lumen.
CONCLUSIONS: This study's findings demonstrated successful reconstruction of the extrahepatic bile duct with a scaffold-free tubular construct created from pig fibroblasts using a novel Bio-3D Printer. This construct could provide a novel regenerative treatment for patients with hepatobiliary diseases.
© 2021 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
Keywords: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Artificial bile duct; Bio-3D printer; Cr, creatinine; DMEM, Dulbecco's Modified Eagle's Medium; EDTA, trypsin-ethylenediaminetetraacetic acid; FBS, fetal bovine serum; IBDI, iatrogenic bile duct injury; KCL, potassium chloride; LDLT, living donor liver transplantation; PBS, phosphate-buffered saline; QOL, quality of life; Reconstruction; Scaffold-free tubular construct; T-Bil, total bilirubin; γ-GTP, γ-glutamyl transpeptidase
Conflict of interest statement
K. Nakayama is a cofounder and shareholder of Cyfuse Biomedical KK. The other authors declare no conflicts of interest.
References
- Tissue Eng Part A. 2015 May;21(9-10):1642-53 - PubMed
- PLoS One. 2015 Sep 01;10(9):e0136681 - PubMed
- World J Gastroenterol. 2006 Jun 14;12(22):3496-511 - PubMed
- Am J Transplant. 2013 Feb;13(2):253-65 - PubMed
- Liver Transpl. 2011 Jan;17(1):47-52 - PubMed
- J Vis Exp. 2013 Jul 07;(77):e3779 - PubMed
- Clin Gastroenterol Hepatol. 2009 Sep;7(9):1013-8; quiz 915 - PubMed
- Eur Surg Res. 2016;56(1-2):61-75 - PubMed
- J Tissue Eng Regen Med. 2017 Apr;11(4):966-976 - PubMed
- Arch Bone Jt Surg. 2018 Mar;6(2):90-99 - PubMed
- Biomaterials. 2018 Jun;167:1-14 - PubMed
- Biomaterials. 2015 Jun;52:452-62 - PubMed
- Vet Immunol Immunopathol. 2002 Sep 25;88(3-4):131-48 - PubMed
- Am J Transplant. 2005 Jun;5(6):1541-7 - PubMed
- Transpl Int. 2005 May;17(12):841-7 - PubMed
- J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:26-32 - PubMed
- Surg Endosc. 2003 Sep;17(9):1362-7 - PubMed
- Am J Pathol. 1997 Aug;151(2):317-22 - PubMed
- Adv Healthc Mater. 2019 Apr;8(7):e1800983 - PubMed
- Visc Med. 2017 Jun;33(3):184-190 - PubMed
- Gut. 1983 Aug;24(8):756-60 - PubMed
- PLoS One. 2019 Mar 8;14(3):e0211339 - PubMed
- Nat Commun. 2019 May 21;10(1):2244 - PubMed
- CMAJ. 2012 May 15;184(8):884-92 - PubMed
- Tissue Eng. 2006 Dec;12(12):3307-39 - PubMed
- Transpl Int. 2011 Apr;24(4):379-92 - PubMed
- ACS Appl Mater Interfaces. 2017 Apr 12;9(14):12290-12298 - PubMed
- Eur Cell Mater. 2003 May 20;5:1-16; discussion 16 - PubMed
- J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):170-5 - PubMed
- Semin Immunol. 2008 Apr;20(2):109-16 - PubMed
- World J Gastroenterol. 2016 Feb 21;22(7):2326-35 - PubMed
- Tissue Eng Part B Rev. 2017 Jun;23(3):237-244 - PubMed
- J Gastrointest Surg. 2012 Mar;16(3):529-34 - PubMed
- Trends Biotechnol. 2013 Feb;31(2):108-15 - PubMed
- Transplant Rev (Orlando). 2017 Jul;31(3):207-217 - PubMed
- Int J Stem Cells. 2019 Jul 31;12(2):183-194 - PubMed
- Am J Gastroenterol. 1999 Feb;94(2):480-3 - PubMed
- Liver Transpl. 2018 Aug;24(8):1050-1061 - PubMed
- Liver Transpl. 2017 Dec;23(12):1519-1530 - PubMed
- Pharmaceuticals (Basel). 2017 Dec 12;10(4): - PubMed
- J Orthop Surg Res. 2014 Oct 14;9:98 - PubMed
- PLoS One. 2017 Feb 13;12(2):e0171448 - PubMed
Publication Types